1. Home
  2. FIX vs REGN Comparison

FIX vs REGN Comparison

Compare FIX & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comfort Systems USA Inc.

FIX

Comfort Systems USA Inc.

HOLD

Current Price

$1,942.43

Market Cap

62.9B

Sector

Industrials

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$604.09

Market Cap

73.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIX
REGN
Founded
1917
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.9B
73.2B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
FIX
REGN
Price
$1,942.43
$604.09
Analyst Decision
Strong Buy
Buy
Analyst Count
6
25
Target Price
$1,798.60
$830.16
AVG Volume (30 Days)
351.2K
989.5K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
0.19%
0.55%
EPS Growth
97.81
8.19
EPS
10.51
6.75
Revenue
$9,101,641,000.00
$5,872,227,000.00
Revenue This Year
$21.43
$12.45
Revenue Next Year
$13.14
$10.13
P/E Ratio
$182.73
$91.17
Revenue Growth
29.52
20.82
52 Week Low
$489.98
$506.38
52 Week High
$2,073.99
$821.11

Technical Indicators

Market Signals
Indicator
FIX
REGN
Relative Strength Index (RSI) 56.58 36.29
Support Level $1,736.87 $591.52
Resistance Level $2,023.33 $618.01
Average True Range (ATR) 99.20 15.46
MACD 4.48 3.14
Stochastic Oscillator 80.12 29.37

Price Performance

Historical Comparison
FIX
REGN

About FIX Comfort Systems USA Inc.

Comfort Systems USA Inc provides comprehensive mechanical contracting services, including heating, ventilation, & air conditioning, or HVAC; plumbing; piping & controls; construction; and other electrical components. Projects are mainly for commercial, industrial, & institutional buildings, & tend to be geared toward HVAC. Revenue is roughly split between installation services for newly constructed facilities & maintenance services for existing buildings. The company installs & repairs products and systems throughout the United States. It operates in two segments, Mechanical services & Electrical services, the majority is from the Mechanical services segment.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: